Prevention of diabetes by manipulation of anti-IGRP autoimmunity: high efficiency of a low-affinity peptide (original) (raw)

• Wraith, D.C., Smilek, D.E., Mitchell, D.J., Steinman, L. & McDevitt, H.O. Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy. Cell 59, 247–255 (1989).
  Article CAS Google Scholar
• Metzler, B. & Wraith, D. Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity. Int. Immunol. 5, 1159–1165 (1993).
  Article CAS Google Scholar
• Liu, G. & Wraith, D. Affinity for class II MHC determines the extent to which soluble peptides tolerize autoreactive T cells in naive and primed adult mice–implications for autoimmunity. Int. Immunol. 7, 1255–1263 (1995).
  Article CAS Google Scholar
• Anderton, S. & Wraith, D. Hierarchy in the ability of T cell epitopes to induce peripheral tolerance to antigens from myelin. Eur. J. Immunol. 28, 1251–1261 (1998).
  Article CAS Google Scholar
• Karin, N., Mitchell, D., Brocke, S., Ling, N. & Steinman, L. Reversal of experimental autoimmune encephalomyelitis by a soluble peptide variant of a myelin basic protein epitope: T cell receptor antagonism and reduction of interferon γ and tumor necrosis factor α production. J. Exp. Med. 180, 2227–2237 (1994).
  Article CAS Google Scholar
• Weiner, H. Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science 259, 1321–1324 (1993).
  Article CAS Google Scholar
• Trentham, D. et al. Effects of oral administration of type II collagen on rheumatoid arthritis. Science 261, 1727–1730 (1993).
  Article CAS Google Scholar
• McKown, K. et al. Lack of efficacy of oral bovine type II collagen added to existing therapy in rheumatoid arthritis. Arthritis Rheum. 42, 1204–1208 (1999).
  Article CAS Google Scholar
• Pozzilli, P. et al. No effect of oral iinsulin on residual beta-cell function in recent-onset type 1 diabetes (the IMDIAB VII). IMDIAB Group. Diabetologia 43, 1000–1004 (2000).
  Article CAS Google Scholar
• Group. D.P.T.-T.D.S. Effects of insulin in relatives of patients with type 1 diabetes mellitus. N. Engl. J. Med. 346, 1685–1691 (2002).
• Kappos, L. et al. Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial. Nat. Med. 6, 1176–1182 (2000).
  Article CAS Google Scholar
• Bielekova, B. et al. Encephalitogenic potential of the myelin basic protein peptide (amino acids 83–99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand. Nat. Med. 6, 1167–1175 (2000).
  Article CAS Google Scholar
• Amrani, A. et al. Progression of autoimmune diabetes driven by avidity maturation of a T-cell population. Nature 406, 739–742 (2000).
  Article CAS Google Scholar
• Santamaria, P. Effector lymphocytes in autoimmunity. Curr. Opin. Immunol. 13, 663–669 (2001).
  Article CAS Google Scholar
• Liblau, R., Wong, S., Mars, L. & Santamaria, P. Autoreactive CD8+ T-cells in organ-specific autoimmunity: emerging targets for therapeutic intervention. Immunity 17, 1–6 (2002).
  Article CAS Google Scholar
• Lieberman, S. & DiLorenzo, T. A comprehensive guide to antibody and T-cell responses in type 1 diabetes. Tissue Antigens 62, 359–377 (2003).
  Article CAS Google Scholar
• Santamaria, P. et al. β-cell-cytotoxic CD8+ T cells from nonobese diabetic mice use highly homologous T cell receptor α-chain CDR3 sequences. J. Immunol. 154, 2494–2503 (1995).
  CAS PubMed Google Scholar
• Verdaguer, J. et al. Acceleration of spontaneous diabetes in TCR-β-transgenic nonobese diabetic mice by β-cell cytotoxic CD8+ T cells expressing identical endogenous TCR-α chains. J. Immunol. 157, 4726–4735 (1996).
  CAS PubMed Google Scholar
• Verdaguer, J. et al. Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice. J. Exp. Med. 186, 1663–1676 (1997).
  Article CAS Google Scholar
• DiLorenzo, T. et al. Major histocompatibility complex class I-restricted T cells are required for all but the end stages oof diabetes development in nonobese diabetic mice and a use prevalent T cell receptor alpha chain gene rearrangement. Proc. Natl Acad. Sci. USA 95, 12538–12543 (1998).
  Article CAS Google Scholar
• Anderson, B., Park, B.J., Verdaguer, J., Amrani, A. & Santamaria, P. Prevalent CD8+ T cell response against one peptide/MHC complex in autoimmune diabetes. Proc. Natl Acad. Sci. USA 96, 9311–9316 (1999).
  Article CAS Google Scholar
• Amrani, A. et al. Expansion of the antigenic repertoire of a single T cell receptor upon T cell activation. J. Immunol. 167, 655–666 (2001).
  Article CAS Google Scholar
• Lieberman, S. et al. Identity of the beta cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes. Proc. Natl Acad. Sci. USA 100, 8384–8388 (2003).
  Article CAS Google Scholar
• Trudeau, J.D. et al. Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood. J. Clin. Invest. 111, 217–223 (2003).
  Article CAS Google Scholar
• Martin, C. et al. Cloning and characterization of the human and rat islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP) genes. J. Biol. Chem. 276, 25197–25204 (2001).
  Article CAS Google Scholar
• Pociot, F. & McDermott, M. Genetics of type 1 diabetes mellitus. Genes Immun. 3, 235–249 (2002).
  Article CAS Google Scholar
• Aichele, P. et al. Peptide-induced T-cell tolerance to prevent autoimmune diabetes in a transgenic mouse model. Proc. Natl Acad. Sci. USA 91, 444–448 (1994).
  Article CAS Google Scholar
• Toes, R., Offringa, R., Blom, R., Melief, C. & Kast, W. Peptide vaccination can lead to enhanced tumor growth through specific T-cell tolerance induction. Proc. Natl Acad. Sci. USA 93, 7855–7860 (1996).
  Article CAS Google Scholar
• Wong, F.S. et al. Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library. Nat. Med. 9, 1026–1031 (1999).
  Article Google Scholar
• Metzler, B., Anderton, S., Manickasingham, S. & Wraith, D. Kinetics of peptide uptake and tissue distribution following a single intranasal dose of peptide. Immunol. Invest. 29, 61–70 (2000).
  Article CAS Google Scholar
• Alexander-Miller, M., Leggatt, G. & Berzofsky, J. Selective expansion of high- or low-avidity cytotoxic T-lymphocytes and efficacy for adoptive immunotherapy. Proc. Natl Acad. Sci. USA 93, 4102–4107 (1996).
  Article CAS Google Scholar
• Perez-Diez, A., Spiess, P., Restifo, N., Matzinger, P. & Marincola, F. Intensity of the vaccine-elicited immune response determines tumor clearance. J. Immunol. 168, 338–347 (2002).
  Article CAS Google Scholar
• Zeh, H., Perry-Lalley, D., Dudley, M., Rosenberg, S. & Yang, J. High avidity CTLS for two self-antigens demonstrate superior in vitro and in vivo anti-tumor efficacy. J. Immunol. 162, 989–994 (1999).
  CAS PubMed Google Scholar
• Arif, S. et al. Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. J. Clin. Invest. 113, 451–463 (2004).
  Article CAS Google Scholar
• Nicholson, L.B., Greer, J.M., Sobel, R.A., Lees, M.B. & Kuchroo, V.K. An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. Immunity 3, 397–405 (1995).
  Article CAS Google Scholar
• Gross, D.A. et al. High vaccination efficiency of low-affinity epitopes in antitumor immunotherapy. J. Clin. Invest. 113, 425–433 (2004).
  Article CAS Google Scholar